Header Logo

Connection

Anthony Burgett to Drug Design

Back to Details
This is a "connection" page, showing publications Anthony Burgett has written about Drug Design.
Anthony Burgett
Connection Strength
0.153
Drug Design
  1. Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes. Bioorg Med Chem. 2018 12 01; 26(22):5766-5779.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.